| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, R&D | Chief Scientific Officer
1 company
Taylor Ian is a President, R&D at ARVINAS, INC.. Recent SEC Form 4 filings include 0 buys and 22 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | ARVN Arvinas, Inc. | President, R&D | Sell | 9,020 | $16.71 | $150,752.20 | -2.7% | -60.1% | -26.0% | |
| Feb 23, 2024 | ARVN Arvinas, Inc. | Chief Scientific Officer | Sell | 1,701 | $47.05 | $80,032.05 | -1.1% | -25.0% | -62.2% | |
| Mar 1, 2023 | ARVN Arvinas, Inc. | Chief Scientific Officer | Sale+OE | 1,051 | $29.53 | $31,036.03 | -1.0% | -28.3% | +50.5% | |
| Mar 4, 2022 | ARVN Arvinas, Inc. | Chief Scientific Officer | Sale+OE | 869 | $63.94 | $55,563.86 | -1.0% | -33.9% | -51.4% | |
| Feb 15, 2022 | ARVN Arvinas, Inc. | Chief Scientific Officer | Sale+OE | 20,000 | $73.02 | $1,460,315.80 | -3.9% | -41.8% | -53.4% | |
| Nov 15, 2021 | ARVN Arvinas, Inc. | Chief Scientific Officer | Sale+OE | 20,000 | $84.04 | $1,680,746.10 | -7.3% | -9.0% | -31.0% | |
| Aug 16, 2021 | ARVN Arvinas, Inc. | Chief Scientific Officer | Sale+OE | 20,000 | $87.30 | $1,745,916.90 | -7.5% | -4.5% | -39.6% | |
| Apr 5, 2021 | ARVN Arvinas, Inc. | Chief Scientific Officer | Sale+OE | 25,000 | $66.81 | $1,670,143.00 | -8.7% | +16.3% | +11.1% | |
| Mar 2, 2021 | ARVN Arvinas, Inc. | Chief Scientific Officer | Sale+OE | 894 | $77.45 | $69,239.85 | -1.1% | -7.7% | -12.2% | |
| Mar 19, 2020 | ARVN Arvinas, Inc. | Chief Scientific Officer | Sale+OE | 826 | $37.61 | $31,065.86 | -1.2% | - | - |